176 related articles for article (PubMed ID: 19036519)
1. In vitro effect of artemether and triclabendazole on adult Fasciola gigantica.
Shalaby HA; El Namaky AH; Kamel RO
Vet Parasitol; 2009 Mar; 160(1-2):76-82. PubMed ID: 19036519
[TBL] [Abstract][Full Text] [Related]
2. An in vitro effect of propolis on adult worms of Fasciola gigantica.
Hegazi AG; Abd El Hady FK; Shalaby HA
Vet Parasitol; 2007 Mar; 144(3-4):279-86. PubMed ID: 17113712
[TBL] [Abstract][Full Text] [Related]
3. Fasciola gigantica: the in vitro effects of artesunate as compared to triclabendazole on the 3-weeks-old juvenile.
Tansatit T; Sahaphong S; Riengrojpitak S; Viyanant V; Sobhon P
Exp Parasitol; 2012 May; 131(1):8-19. PubMed ID: 22425749
[TBL] [Abstract][Full Text] [Related]
4. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
Parasitology; 2006 Aug; 133(Pt 2):195-208. PubMed ID: 16650337
[TBL] [Abstract][Full Text] [Related]
5. Fasciola gigantica: Parasitological and scanning electron microscopy study of the in vitro effects of ivermectin and/or artemether.
Diab TM; Mansour HH; Mahmoud SS
Exp Parasitol; 2010 Mar; 124(3):279-84. PubMed ID: 19861124
[TBL] [Abstract][Full Text] [Related]
6. Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).
Stitt AW; Fairweather I
Parasitol Res; 1993; 79(7):529-36. PubMed ID: 8278333
[TBL] [Abstract][Full Text] [Related]
7. Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether.
Keiser J; Morson G
Exp Parasitol; 2008 Feb; 118(2):228-37. PubMed ID: 17888906
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent tegumental surface changes in juvenile Fasciola gigantica in response to triclabendazole treatment in goat.
Shareef PA; Brennan GP; McVeigh P; Khan MA; Morphew RM; Mousley A; Marks NJ; Saifullah MK; Brophy PM; Maule AG; Abidi SM
Acta Trop; 2014 Aug; 136():108-17. PubMed ID: 24742909
[TBL] [Abstract][Full Text] [Related]
9. Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.
O'Neill JF; Johnston RC; Halferty L; Brennan GP; Keiser J; Fairweather I
J Helminthol; 2009 Jun; 83(2):151-63. PubMed ID: 19368748
[TBL] [Abstract][Full Text] [Related]
10. Fasciola gigantica: anthelmintic effect of the aqueous extract of Artocarpus lakoocha.
Saowakon N; Tansatit T; Wanichanon C; Chanakul W; Reutrakul V; Sobhon P
Exp Parasitol; 2009 Aug; 122(4):289-98. PubMed ID: 19393239
[TBL] [Abstract][Full Text] [Related]
11. Tegumental surface changes in adult Paramphistomum microbothrium (Fischoeder 1901) following in vitro administration of artemether.
Shalaby HA; El Namaky AH; Kamel RA; Derbala AA
J Helminthol; 2010 Jun; 84(2):115-22. PubMed ID: 19691911
[TBL] [Abstract][Full Text] [Related]
12. Tegumental alterations of Fasciola gigantica due to in vitro treatment with Ro-354.
Soliman MI; Taha HA
Trop Biomed; 2011 Aug; 28(2):283-92. PubMed ID: 22041747
[TBL] [Abstract][Full Text] [Related]
13. The in vitro anthelmintic effects of plumbagin on newly excysted and 4-weeks-old juvenile parasites of Fasciola gigantica.
Lorsuwannarat N; Piedrafita D; Chantree P; Sansri V; Songkoomkrong S; Bantuchai S; Sangpairot K; Kueakhai P; Changklungmoa N; Chaichanasak P; Chansela P; Sobhon P
Exp Parasitol; 2014 Jan; 136():5-13. PubMed ID: 24157317
[TBL] [Abstract][Full Text] [Related]
14. The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica.
Stitt AW; Fairweather I
Parasitology; 1994 Jun; 108 ( Pt 5)():555-67. PubMed ID: 8052511
[TBL] [Abstract][Full Text] [Related]
15. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I
Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238
[TBL] [Abstract][Full Text] [Related]
16. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
[TBL] [Abstract][Full Text] [Related]
17. Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole.
Meaney M; Fairweather I; Brennan GP; Ramasamy P; Subramanian PB
Parasitol Res; 2002 Apr; 88(4):315-25. PubMed ID: 11999018
[TBL] [Abstract][Full Text] [Related]
18. Detoxifying and anti-oxidant enzymes of Fasciola gigantica worms under triclabendazole sulphoxide (TCBZ-SX): an in vitro study.
Shehab AY; Ebeid SM; El-Samak MY; Hussein NM
J Egypt Soc Parasitol; 2009 Apr; 39(1):73-83. PubMed ID: 19530611
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
Vet Parasitol; 2010 Dec; 174(3-4):218-27. PubMed ID: 20933333
[TBL] [Abstract][Full Text] [Related]
20. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
